2nd-Ever Post-Grant Review Ends In Settlement

Law360, New York (November 25, 2014, 5:03 PM EST) -- The Patent Trial and Appeal Board on Monday approved a settlement between Accord Healthcare Inc. and drugmakers Helsinn Healthcare SA and Roche Palo Alto LLC over a patent on nausea drug Aloxi, ending the second-ever post-grant review proceeding under the America Invents Act.

The approval came three days after the parties informed the PTAB of their confidential settlement, which not only ends the proceedings before the board but also resolves a related patent infringement lawsuit Helsinn and the Roche subsidiary had filed against generic-drug maker Accord last year over an application for a generic form of Aloxi. In its order, the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!